Mayo Clinic researchers are investigating:

  • Urine-based marker tests for detecting urothelial cancer of the ureter, bladder and kidneys. Urine-based marker tests are generally noninvasive and potentially reliable for detecting low-grade urothelial cancer. The tests identify key urine indicators that suggest cancer recurrence.
  • Drugs for treating advanced urothelial cancer.
  • Experimental treatments for urothelial cancer.
  • New tissue-based markers for detecting and managing urothelial cancer.

Publications

See a list of publications by Mayo doctors on urothelial cancer on PubMed, a service of the National Library of Medicine.

Jun. 27, 2013